There is also a lack of research on the implications of type II NKTs in GBM, but the ability of these cells to indirectly suppress CD8+ T cell activity in the context of other tumors indicates that they may be important immunosuppressive cells in GBM as well. The gene discussed is CD8A; the disease is glioblastoma.